Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 2Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Colorectal Neoplasms 47Squamous Cell Carcinoma of Head and Neck 19Carcinoma, Non-Small-Cell Lung 15Neoplasms 12Head and Neck Neoplasms 9Neoplasm Metastasis 8Lung Neoplasms 8Carcinoma, Squamous Cell 7Pancreatic Neoplasms 6Colonic Neoplasms 6Solid Tumors 5Rectal Neoplasms 4Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Gastrointestinal Neoplasms 3Colorectal Cancer Metastatic 3Carcinoma 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Recurrence 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Melanoma 2Locally Recurrent Rectal Cancer 2Endometrial Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Pancreatic Ductal 2Advanced Solid Tumor 2

Interventions

Magnetic Resonance Spectroscopy 19Temozolomide 16Radiotherapy 10Specimen Handling 7Blood Specimen Collection 7Radiation 6Bevacizumab 5Nivolumab 4Cyclophosphamide 4Biopsy 4vorasidenib 3trametinib 3pembrolizumab 3olaparib 3fludarabine 3dabrafenib 3Watchful Waiting 3Surgical Procedures, Operative 3Magnetic Resonance Imaging 3Drug Therapy 3olutasidenib 2lutetium Lu 177 dotatate 2fluorodopa F 18 2fluciclovine F-18 2entrectinib 2contrast agent BR1 2Restraint, Physical 2Radiosurgery 2Microdialysis 2Flucytosine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Glioma × Cetuximab × Clear all
NCT05355701 2026-06-05

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Pfizer

Phase 1 Recruiting
267 enrolled
CNSDermatologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Melanoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡